top of page
Pub_01_oben

01 - Indicatori di qualità dell'assistenza dei medici di medicina generale/ Misurazione e monitoraggio della qualità del trattamento.

2024

 

Blood pressure control and antihypertensive treatment in Swiss general practice: a cross-sectional study using routine data

Di Gangi S, Brenner R, Grischott T, Burgstaller JM, Senn O, Rosemann T, Markun S

Swiss Med Wkly. 2024;154:3898

> Leggere

Elevated TSH Levels: A Database Study of General Practitioners’ Course of Action

Jäger L, Burgstaller JM, Zechmann S, Senn O, Rosemann T, MarkunS

Endocrine Practice 30 (2024) 187-193

> Leggere

 

2022

Quality and variation of care for chronic kidney disease in Swiss general practice: A retrospective database study

Jäger L, Rosemann T, Burgstaller JM, Senn O, Markun S

PLoS One. 2022 Aug 11;17(8):e0272662.

> Leggere

Quality outcome of diabetes care during COVID-19 pandemic: a primary care cohort study

Di Gangi S, Lüthi B, Diaz Hernandez L, Zeller A, Zechmann S, Fischer R

Acta Diabetologica volume 59, pages 1189–1200 (2022).

> Leggere

 

2021

Long-Term Effects of Financial Incentives for General Practitioners on Quality Indicators in the Treatment of Patients With Diabetes Mellitus in Primary Care—A Follow-Up Analysis of a Cluster Randomized Parallel Controlled Trial

Meier R, Chmiel C, Valeri F, Muheim L, Senn O, Rosemann T

Front. Med., 26 October 2021

> Leggere

The Effect of Financial Incentives on Quality Measures in the Treatment of Diabetes Mellitus: a Randomized Controlled Trial

Meier R, Chmiel C, Valeri F, Muheim L, Senn O, Rosemann T

Journal of General Internal Medicine volume 37, pages 556–564

> Leggere

Physician-dispensing as a determinant of clinical and process measurements in patients at increased cardiovascular risk: A cross-sectional study in Swiss general practice

Rachamin Y, Meier R, Valeri F, Rosemann T, Muheim L

Health Policy Volume 125, Issue 10, October 2021, Pages 1305-1310

> Leggere

Inferior control of low-density lipoprotein cholesterol in women is the primary sex difference in modifiable cardiovascular risk: A large-scale, cross-sectional study in primary care

Rachamin Y, Grischott T, Rosemann T, Meyer MR

Atherosclerosis. 2021;324:141-147

> Leggere

2020

Guideline Concordance of Statin Treatment Decisions: A Retrospective Cohort Study

Rachamin Y, Markun S, Grischott T, Rosemann T, Meier R

J Clin Med. 2020;9(11):3719

> Leggere

The Impact of the 2019 European Guideline for Cardiovascular Risk Management: A Cross-Sectional Study in General Practice

Meier R, Rachamin Y, Rosemann T, Markun S

J Clin Med. 2020;9(7):2140

> Leggere

Statin treatment and LDL target value achievement in Swiss general practice – a retrospective observational study

Rachamin Y, Meier R, Rosemann T, Langenegger S, Markun S

Swiss Med Wkly. 2020;150:w20244

> Leggere

Quality performance and associated factors in Swiss diabetes care – A cross-sectional study

Meier R, Valeri F, Senn O, Rosemann T, Chmiel C

PLoS One. 2020;15(5):e0232686

> Leggere

Gout management in Swiss primary care – a retrospective observational study

Meier R, Di Gangi S, Valeri F, Rosemann T, Zechmann S, and the FIRE study group

Swiss Med Wkly. 2020;150:w20209

> Leggere

2019

Indications and associated factors for prescribing intravenous iron supplementation in Swiss general practice: a retrospective observational study

Meier R, Keizer E, Rosemann T, Markun S

Swiss Med Wkly. 2019;149:w20127

> Leggere

2017

Aspects of the quality of care for patients with PAD

Ursprung N, Senn O, Djalali S

Z Allg Med. 2017;93(12)

> Leggere

The impact of an individualized risk-adjusted approach on hypertension treatment in primary care

Zechmann S, Senn O, Valeri F, Neuner-Jehle S, Rosemann T, Djalali S and the FIRE study group

J Clin Hypertens (Greenwich). 2017;19(5):510-518

> Leggere

Anticoagulation Control in Swiss Primary Care: Time in Therapeutic Range Percentages Exceed Benchmarks of Phase III Trials

Djalali S, Valeri F, Gerber B, Meli DN, Senn O

Clin Appl Thromb Hemost. 2017;23(6):685-695

> Leggere

2016

Quality of secondary prevention of coronary heart disease in Swiss primary care: Lessons learned from a 6-year observational study

Scherz N, Valeri F, Rosemann T, Djalali S

Z Evid Fortbild Qual Gesundhwes. 2016;118-119:40-7

> Leggere

2015

General Practitioners’ vitamin K antagonist monitoring is associated with better blood pressure control in patients with hypertension – a cross-sectional database study

Streit S, Kaplan V, Busato A, Djalali S, Senn O, Meli DN and the FIRE study group

BMC Cardiovasc Disord. 2015;15(1):47

> Leggere

2014

Swiss Quality and Outcomes Framework: Quality Indicators for Diabetes Management in Swiss Primary Care Based on Electronic Medical Records

Djalali S, Frei A, Tandjung R, Baltensperger A, Rosemann T

Gerontology. 2014;60(3):263-73

> Leggere

bottom of page